A detailed history of Titleist Asset Management, Ltd. transactions in Viatris Inc stock. As of the latest transaction made, Titleist Asset Management, Ltd. holds 31,225 shares of VTRS stock, worth $331,921. This represents 0.08% of its overall portfolio holdings.

Number of Shares
31,225
Previous 29,832 4.67%
Holding current value
$331,921
Previous $254,000 36.61%
% of portfolio
0.08%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

BUY
$8.72 - $11.56 $12,146 - $16,103
1,393 Added 4.67%
31,225 $0
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $7,021 - $9,215
828 Added 2.85%
29,832 $254,000
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $14,288 - $17,619
-1,436 Reduced 4.72%
29,004 $304,000
Q1 2022

May 04, 2022

BUY
$9.81 - $15.4 $20,689 - $32,478
2,109 Added 7.44%
30,440 $331,000
Q4 2021

Feb 17, 2022

BUY
$12.09 - $14.68 $342,521 - $415,899
28,331 New
28,331 $383,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Titleist Asset Management, Ltd. Portfolio

Follow Titleist Asset Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Titleist Asset Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Titleist Asset Management, Ltd. with notifications on news.